Romidepsin: Evidence for Its Potential Use to Manage Previously Treated Cutaneous T Cell Lymphoma

Core Evidence - New Zealand
doi 10.2147/ce.s9084
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited